Table 2.
Study | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | Overall |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Murase et al. | 1 | 2 | 2 | 2 | 1 | 1 | 2 | 2 | 0 | 0 | 2 | 0 | 1 | 2 | 2 | 2 | 0 | 2 | 1 | 2 | 1 | 0 | 28 |
Doherty et al. | 2 | 2 | 2 | 2 | 1 | 1 | 2 | 2 | 1 | 0 | 2 | 2 | 2 | 2 | 2 | 2 | 0 | 2 | 2 | 2 | 2 | 1 | 36 |
Drinkwater et al. | 1 | 2 | 2 | 2 | 1 | 1 | 2 | 1 | 0 | 0 | 2 | 2 | 1 | 2 | 2 | 2 | 0 | 2 | 1 | 2 | 1 | 0 | 29 |
Coyle et al. | 1 | 2 | 2 | 2 | 1 | 1 | 2 | 2 | 1 | 0 | 2 | 2 | 1 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 1 | 2 | 35 |
Esatwood et al. | 1 | 2 | 2 | 2 | 1 | 1 | 2 | 1 | 1 | 0 | 2 | 2 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 35 |
Houmard et al. | 1 | 2 | 2 | 2 | 1 | 1 | 2 | 2 | 1 | 0 | 2 | 2 | 1 | 2 | 2 | 2 | 2 | 2 | 0 | 1 | 2 | 2 | 34 |
Yi-hung et al. | 1 | 2 | 2 | 2 | 1 | 2 | 2 | 2 | 2 | 0 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 2 | 2 | 39 |
Petibois et al. | 1 | 2 | 2 | 2 | 1 | 1 | 2 | 2 | 1 | 0 | 2 | 2 | 1 | 2 | 2 | 2 | 1 | 2 | 1 | 2 | 2 | 2 | 35 |
Balague et al. | 1 | 2 | 2 | 2 | 1 | 1 | 2 | 2 | 1 | 0 | 2 | 2 | 2 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 37 |
Garcia et al. | 2 | 2 | 2 | 2 | 1 | 1 | 2 | 2 | 0 | 0 | 2 | 2 | 2 | 2 | 2 | 2 | 0 | 2 | 2 | 2 | 1 | 1 | 34 |
LaForgia et al. | 2 | 2 | 2 | 2 | 1 | 1 | 2 | 2 | 2 | 0 | 2 | 2 | 1 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 1 | 0 | 35 |
Mochizuki et al. | 1 | 2 | 2 | 2 | 1 | 1 | 2 | 2 | 2 | 0 | 2 | 2 | 1 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 2 | 0 | 35 |
Androulakis et al. | 1 | 2 | 2 | 2 | 1 | 2 | 2 | 2 | 2 | 0 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 39 |
TRAVLOS et al. | 1 | 2 | 2 | 2 | 1 | 2 | 2 | 2 | 1 | 0 | 2 | 0 | 2 | 1 | 2 | 2 | 0 | 2 | 0 | 1 | 2 | 0 | 29 |
BRIAN et al. | 1 | 2 | 2 | 2 | 1 | 1 | 2 | 1 | 2 | 0 | 2 | 0 | 2 | 1 | 2 | 2 | 0 | 2 | 2 | 2 | 2 | 1 | 32 |
Nikolaos et al. | 1 | 2 | 2 | 2 | 1 | 2 | 2 | 2 | 2 | 0 | 2 | 0 | 2 | 1 | 2 | 2 | 0 | 2 | 2 | 2 | 2 | 1 | 34 |
Gamelin et al. | 1 | 2 | 2 | 2 | 1 | 2 | 2 | 2 | 2 | 0 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 0 | 38 |
Eileen et al. | 1 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 0 | 2 | 2 | 1 | 2 | 2 | 2 | 1 | 2 | 2 | 1 | 2 | 0 | 31 |
Melchiorri et al. | 1 | 2 | 2 | 2 | 1 | 1 | 2 | 2 | 2 | 0 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 1 | 2 | 2 | 0 | 35 |
KLAVS et al. | 1 | 2 | 2 | 2 | 1 | 1 | 2 | 2 | 1 | 0 | 2 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 1 | 1 | 33 |
Miharu et al. | 1 | 2 | 2 | 2 | 1 | 1 | 2 | 2 | 1 | 0 | 2 | 0 | 1 | 2 | 2 | 1 | 2 | 0 | 1 | 2 | 2 | 1 | 30 |
1: title and abstract; 2: background/rationale; 3: objectives; 4: study design; 5: setting; 6: participants; 7: variables; 8: data sources/measurement; 9: bias; 10: study size; 11: quantitative variables; 12: statistical methods; 13: participants; 14: descriptive data; 15: outcome data; 16: main results; 17: other analyses; 18: key results; 19: limitations; 20: interpretation; 21: generalizability; and 22: funding (0: no information; 1: low; and 2: high).